Lupin inks pact with Alvion to market drugs in Southeast Asia
Drug maker Lupin on Tuesday said it has inked a licensing pact with Alvion Pharmaceuticals to commercialise medicines for cardio metabolic diseases in ...
Begin typing your search...
You Searched For "Lupin"
USFDA issues warning letter on Lupin's Somerset facility, cites...
In its warning letter USFDA pointed out three major violations of current good manufacturing practices (cGMP) at Somerset site. These include firm's...
Lupin introduces digital educator platform for asthma patients
Lupin has launched its digital asthma educator platform.
Lupin change gears to bring Covid-19 drugs in market; approaches...
Lupin has approached Gilead Sciences Inc for a voluntary license, or an authorisation given by a patent holder to a generics producer, to manufacture...
Lupin change gears to bring Covid-19 drugs in market; approaches...
Lupin has approached Gilead Sciences Inc for a voluntary license, or an authorisation given by a patent holder to a generics producer, to manufacture...
Lupin share dips 2% after delayed-release of Posaconazole tablets
The company has launched Posaconazole delayed-release tablets with the approval of the United States Food and Drug Administration (USFDA).
Lupin reports Rs 438.3 crore net profit in Q3 FY21
Drugmaker Lupin reported a net profit (profit after tax) of Rs 438.3 crore in the quarter ended December 31 led by growth of sales in the US, India...
Lupin launches generic immunosuppressant drug in US
Its alliance partner Concord Biotech received approval from FDA
